COVID vaccine made by Canada's Medicago shows promising results in Phase 2 clinical trial

Canada's first homegrown vaccine for COVID-19 is showing promising antibody results in hundreds of participants in a Phase 2 trial and could be ready for a final authorization request this summer, the drugmaker says.